Praxis Precision Medicines, Inc. — Director's Dealing 2021

Jun 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Praxis Precision Medicines, Inc. (PRAX)
CIK: 0001689548
Period of Report: 2021-06-08

Reporting Person: YOUNG WILLIAM D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-08	Stock Option (Right to Buy)	$20.42	A	22343	Acquired	2031-06-08	Common Stock (22343.0)	Direct

Footnotes

F1: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 8, 2021.